Back to top

Image: Bigstock

Top Ranked Value Stocks to Buy for March 11th

Read MoreHide Full Article

Here are four stocks with buy rank and strong value characteristics for investors to consider today, March 11th:

CAI International, Inc. : This transportation finance and logistics company has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 45.7% over the last 60 days.

 

CAI International has a price-to-earnings ratio (P/E) of 6.43, compared with 44.40 for the industry. The company possesses a Value Score of A.

 

Danaos Corporation (DAC - Free Report) : This owner and operator of containerships has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 30.2% over the last 60 days.

 

Danaos Corp. has a price-to-earnings ratio (P/E) of 3.02, compared with 4.00 for the industry. The company possesses a Value Score of A.

 

Danaos Corporation PE Ratio (TTM)

Danaos Corporation PE Ratio (TTM)

Danaos Corporation pe-ratio-ttm | Danaos Corporation Quote

 

Oasis Midstream Partners LP : This provider of crude oil, natural gas and water-related midstream services has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 22.4% over the last 60 days.

 

Oasis Midstream Partners has a price-to-earnings ratio (P/E) of 6.65, compared with 9.00 for the industry. The company possesses a Value Score of A.

 

Taylor Morrison Home Corporation (TMHC - Free Report) : This public homebuilder has a Zacks Rank #2, and seen the Zacks Consensus Estimate for its current year earnings rising 15.5% over the last 60 days.

 

Taylor Morrison Home has a price-to-earnings ratio (P/E) of 5.99, compared with 10.80 for the industry. The company possesses a Value Score of A.

 

See the full list of top ranked stocks here.

Learn more about the Value score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Taylor Morrison Home Corporation (TMHC) - free report >>

Danaos Corporation (DAC) - free report >>

Published in